Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2025-12-24 @ 5:43 PM
NCT ID:
NCT05244668
Eligibility Criteria:
Inclusion Criteria:
* Patient aged between 18 and 43 years,
* Patient having dated and signed the consent form,
* Patient affiliated to the French health system,
* Patient with pelvic MRI and/or pelvic ultrasound,
* Patient from one of the 3 study populations:
* Patient with a formal endometriosis diagnosed by clinical examination and imaging AND an indication for specialised endometriosis follow-up or medically assisted procreation (MAP) or surgery validated by RCP (in routine care);
* Patient with suspected endometriosis for whom the diagnosis is the source of a discrepancy between clinical and radiological data AND a surgical indication validated by RCP (in routine care);
* Patient with a gynaecological indication for surgery of the small pelvis by laparoscopy or laparoscopy validated in RCP (in routine care) AND symptoms suggestive of endometriosis (dysmenorrhoea, ....)(1).
Exclusion Criteria:
* Patient with recurrence of deep endometriosis (excluding endometrioma),
* Patient with endometriosis of the torus and/or utero-sacral ligaments without indication for surgery,
* Patient with parietal endometriosis alone without indication for surgery,
* Patient with adenomyosis alone on imaging without indication for surgery,
* Patient with gynaecological infection requiring surgical management,
* Pregnant patient,
* Patient infected with the human immunodeficiency virus (HIV),
* Patient with significant difficulties in reading or writing the French language,
* Patient with a personal history of cancer,
* Patient unable to comply with study and/or follow-up procedures,
* Patient who has objected to the collection of her data.
* Patient participating in another clinical research study.
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
43 Years
Study:
NCT05244668
Study Brief:
Protocol Section:
NCT05244668